Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostate Cancer Metastatic 1Oropharyngeal Neoplasms 1Oligometastatic Squamous Cell Carcinoma of the Head and Neck 1Neoplasm, Residual 1Mouth Neoplasms 1Mesothelioma 1Melanoma 1Leukemia, Myeloid, Chronic-Phase 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hodgkin Disease 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma 1Breast Neoplasms 1Biliary Tract Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Taxes 2Specimen Handling 2Paclitaxel 2Docetaxel 2pembrolizumab 1Surgical Procedures, Operative 1Standard of Care 1Practice Guidelines as Topic 1Doxorubicin 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Anatomic Stage I Breast Cancer AJCC v8 × pembrolizumab × Clear all
NCT05929768 2025-11-05

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

SWOG Cancer Research Network

Phase 3 Recruiting
2,400 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡